3rd ESCMID Conference on Vaccines - Vaccines for Mutual Protection
6 - 8 March 2015, Lisbon, Portugal
Poster Presentations
Chlamydial Type III Secretion Proteins as Novel Vaccine Candidates.
David Bulir
Epidemiology of adult pneumococcal meningitis in the early post PCV era; A nation-wide study, Israel
Gili Regev-Yochay
Development of Pneumococcal-Typhoid Bivalent Vaccine
Neha Kothari
Vaccine coverage and determinants of incomplete vaccination in children aged 12-23 months in Dschang, West Cameroon: a cross-sectional survey during a Polio outbreak.
Alessandro Miglietta
Awareness of Human Papillomavirus (HPV) infection and willigness to HPV vaccination among males at risk for sexually transmitted infections
Maria Gabriella Dona´
Epidemiology of invasive pneumococcal disease in adults following introduction of conjugate pneumococcal vaccine; experience of a single
Corinna Sadlier
Downregulation of NK cell activity by H. pylori LPS - a way to induce tolerance ?
Karolina Rudnicka
The impact of influenza vaccination on the activation and apoptosis of immune cells in children with allergic diseases
Vilya Bulgakova
Extension of the United Kingdom Influenza Immunisation Programme 2013/2014 to Children and the Implications for High-Risk Group Uptake
Sankarasubramanian Rajaram
Hepatitis A: universal vaccination for adult travelers?
Sónia Duarte Rocha
Meningococcal vaccination strategy in the Czech Republic
Pavla Krizova
Seasonal and pandemic influenza vaccination coverage in pregnant women in Spain. Are we forgetting this influenza high-risk group?
Luz Maria Vilca
Risk Factors Associated for Community-Acquired Pneumonia among Hospitalized Patients: the Risk Stacking Impact
Alejandro Cané
Seroprevalence of antibodies against the virus Measles, Mumps and Rubella in the student population of the Area Health Serrania de Málaga, Spain
Maria Jesús
Human papillomavirus vaccination in Portugal, October 2008 to June 2014
Joana Cortez
Effective measles elimination strategy in Portugal
Teresa Fernandes
A Randomized, Double-Blind, Phase III Trial to Assess the Immunogenicity and Safety of NBP606, a new 13-valent pneumococcal conjugate vaccine
Myoung-don OH
Pneumococcal conjugate vaccines - impact in the Czech Republic
Jana Kozakova
Live Enterovirus Vaccines as oncolytic agents applicable for cancer therapy
Demina A.V.
Seroprevalence HVB and knowledge about Hepatitis B vaccine in pregnancy in Abidjan_Cote D’Ivoire
Kouassi-M´Bengue A
Measles and Rubella Elimination in Italy: Parvovirus B19 in the differential diagnosis
Melissa Baggieri
Evaluation of the Admission Reasons and the Response Rates of the HBV Vaccination at the Adult Vaccination Polyclinic
Sukran Kose
Serotypes of Streptococcus pneumoniae from children with tuberculosis and tuberculosis hospital staff
Julia Skurikhina
Recombinant Trichina Spiralis 53kDa Protein Directly Activates Macrophages in M2 Pattern in vitro.
Zhongfu Ma
Serotype replacement – a challenge to pneumococcal conjugate vaccine efficacy
Radka Komitova
Barriers and Motivators of Seasonal Influenza vaccine uptake between Iranian Healthcare workers during 2012/2013 season
Mohammad Darvishi
An analysis of government immunization program expenditures in lower and lower middle income countries 2006-12
Alice Abou Nader
Colonisation of the pharynx by s.pneumoniae in older children and adolescents in an area characterised by limited pneumococcal vaccination coverage
Claudia Tagliabue